Literature DB >> 15084500

Candida infections of medical devices.

Erna M Kojic1, Rabih O Darouiche.   

Abstract

The number of indwelling medical devices is escalating, and an increasing proportion of device-related infections are being caused by Candida spp. Candida spp. produce biofilms on synthetic materials, which facilitates adhesion of the organisms to devices and renders them relatively refractory to medical therapy. Management of device-related Candida infections can be challenging. Removal of the infected device is generally needed to establish cure of Candida infections of medical devices. However, since the pathogenesis of Candida bloodstream infection is complicated, more studies are necessary to determine the role of catheter exchange in patients with both gastrointestinal tract mucositis and indwelling catheters. The medical and economic impact of these infections is enormous.

Entities:  

Mesh:

Year:  2004        PMID: 15084500      PMCID: PMC387407          DOI: 10.1128/CMR.17.2.255-267.2004

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  122 in total

Review 1.  Infection in patients after implantation of an orthopedic device.

Authors:  G Stocks; H F Janssen
Journal:  ASAIO J       Date:  2000 Nov-Dec       Impact factor: 2.872

2.  The virulence of Staphylococcus pyogenes for man; a study of the problems of wound infection.

Authors:  S D ELEK; P E CONEN
Journal:  Br J Exp Pathol       Date:  1957-12

Review 3.  Infections associated with uremia and dialysis.

Authors:  V R Minnaganti; B A Cunha
Journal:  Infect Dis Clin North Am       Date:  2001-06       Impact factor: 5.982

4.  Salvage of infected orthopedic devices.

Authors:  A W Karchmer
Journal:  Clin Infect Dis       Date:  1998-10       Impact factor: 9.079

5.  Quantitative variation of biofilms among strains in natural populations of Candida albicans.

Authors:  Xiaogang Li; Zhun Yan; Jianping Xu
Journal:  Microbiology       Date:  2003-02       Impact factor: 2.777

6.  The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance.

Authors:  M H Nguyen; J E Peacock; A J Morris; D C Tanner; M L Nguyen; D R Snydman; M M Wagener; M G Rinaldi; V L Yu
Journal:  Am J Med       Date:  1996-06       Impact factor: 4.965

Review 7.  Pacemaker endocarditis due to Candida albicans: case report and review.

Authors:  V Joly; N Belmatoug; A Leperre; J Robert; F Jault; C Carbon; P Yeni
Journal:  Clin Infect Dis       Date:  1997-12       Impact factor: 9.079

8.  Candida albicans pacemaker site infection.

Authors:  T J Cohen; V G Pons; J Schwartz; J C Griffin
Journal:  Pacing Clin Electrophysiol       Date:  1991-02       Impact factor: 1.976

9.  Does surgical approach affect the incidence of inflatable penile prosthesis infection?

Authors:  B B Garber; S M Marcus
Journal:  Urology       Date:  1998-08       Impact factor: 2.649

10.  Infections after cardioverter-defibrillator implantation: observations in 335 patients over 10 years.

Authors:  H J Trappe; P Pfitzner; H Klein; P Wenzlaff
Journal:  Br Heart J       Date:  1995-01
View more
  329 in total

1.  Canadian clinical practice guidelines for invasive candidiasis in adults.

Authors:  Eric J Bow; Gerald Evans; Jeff Fuller; Michel Laverdière; Coleman Rotstein; Robert Rennie; Stephen D Shafran; Don Sheppard; Sylvie Carle; Peter Phillips; Donald C Vinh
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

Review 2.  Candida albicans Biofilms and Human Disease.

Authors:  Clarissa J Nobile; Alexander D Johnson
Journal:  Annu Rev Microbiol       Date:  2015       Impact factor: 15.500

3.  Genetic control of Candida albicans biofilm development.

Authors:  Jonathan S Finkel; Aaron P Mitchell
Journal:  Nat Rev Microbiol       Date:  2010-12-29       Impact factor: 60.633

4.  Genome-wide transcription profiling of the early phase of biofilm formation by Candida albicans.

Authors:  Luis A Murillo; George Newport; Chung-Yu Lan; Stefan Habelitz; Jan Dungan; Nina M Agabian
Journal:  Eukaryot Cell       Date:  2005-09

Review 5.  Candida biofilms: an update.

Authors:  Gordon Ramage; Stephen P Saville; Derek P Thomas; José L López-Ribot
Journal:  Eukaryot Cell       Date:  2005-04

6.  Candida albicans Sfl1 suppresses flocculation and filamentation.

Authors:  Janine Bauer; Jürgen Wendland
Journal:  Eukaryot Cell       Date:  2007-08-31

7.  Small-molecule suppressors of Candida albicans biofilm formation synergistically enhance the antifungal activity of amphotericin B against clinical Candida isolates.

Authors:  Jianlan You; Lin Du; Jarrod B King; Brian E Hall; Robert H Cichewicz
Journal:  ACS Chem Biol       Date:  2013-02-14       Impact factor: 5.100

8.  In vitro study of sequential fluconazole and caspofungin treatment against Candida albicans biofilms.

Authors:  Semanti Sarkar; Priya Uppuluri; Christopher G Pierce; Jose L Lopez-Ribot
Journal:  Antimicrob Agents Chemother       Date:  2013-11-11       Impact factor: 5.191

9.  Expression of UME6, a key regulator of Candida albicans hyphal development, enhances biofilm formation via Hgc1- and Sun41-dependent mechanisms.

Authors:  Mohua Banerjee; Priya Uppuluri; Xiang R Zhao; Patricia L Carlisle; Geethanjali Vipulanandan; Cristina C Villar; José L López-Ribot; David Kadosh
Journal:  Eukaryot Cell       Date:  2012-12-07

10.  Inhibition of Candida albicans biofilm formation by antimycotics released from modified polydimethyl siloxane.

Authors:  Kristof De Prijck; Nele De Smet; Kris Honraet; Steven Christiaen; Tom Coenye; Etienne Schacht; Hans J Nelis
Journal:  Mycopathologia       Date:  2009-09-23       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.